We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bioventix Plc | LSE:BVXP | London | Ordinary Share | GB00B4QVDF07 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
25.00 | 0.57% | 4,375.00 | 4,300.00 | 4,450.00 | 4,375.00 | 4,350.00 | 4,350.00 | 4,223 | 14:16:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 12.82M | 8.37M | 1.6071 | 27.22 | 227.91M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/10/2016 12:39 | Into auction with a price monitoring extension! | rcturner2 | |
10/10/2016 11:15 | Thanks Leon, that explains the sharp rise then I guess! It's one of those stocks I've tucked away and largely forgotten about for the last couple of years. Are you still long term bullish on BVXP? Many thanks, James | jimbobjames2002 | |
10/10/2016 11:12 | Penny Share! They're 13 quid a pop !! | stepone68 | |
10/10/2016 10:47 | Tipped in the Penny Share Letter | boros10 | |
10/10/2016 09:32 | Perhaps positive currency effect finally being twigged. | igbertsponk | |
10/10/2016 09:20 | Maybe some interest in anticipation of good results next Monday. | impvesta | |
10/10/2016 08:58 | Large number of buys at open - tipped somewhere at weekend?? | sharw | |
26/8/2016 19:40 | some large buys going through today at 1130. expect RNS? | melody9999 | |
24/8/2016 13:44 | Games being played today imo. Far more buys than sells. | martinthebrave | |
22/8/2016 10:30 | That's true RC, but his timing couldn't have been worse :-) | stepone68 | |
22/8/2016 10:03 | On a small stock such as this I don't think charts are much of a guide. There are simply too few people buying and selling the share to believe that the chart contains accurate signals. | rcturner2 | |
22/8/2016 09:46 | 1birddog 19 Aug'16 - 09:26 - 311 of 331 chart look ready to roll over hairy chart Nice timing from 1birddog on Friday :-) | stepone68 | |
22/8/2016 09:10 | That's more like it re price reaction, a very good opportunity to add first thing in hindsight. | hydrus | |
22/8/2016 08:52 | I agree Jombaston, profits likely to be substantially higher proportionally than revenue but even with the conservative calculation above it looks cheap. | hydrus | |
22/8/2016 08:46 | £5.3m revenues compares with £4.8m which had been expected (a year ago the forecast was £4.5m). Because of the nature of revenues (largely royalties) this will drop through to the bottom line. So although it only says profits ahead of expectations, it seems to me they could have said 'significantly' or 'substantially'. However, their announcements have tended to be cautious which is why they haven't been more specific about the troponin revenue stream. | jombaston | |
22/8/2016 08:41 | I agree Hydrus. I am 'fully loaded' already so cannot add more but great news both on current year and future prospects. | melody9999 | |
22/8/2016 08:38 | Anyway, maybe it's just me but I added first thing, seems like a decent bet. | hydrus | |
22/8/2016 08:37 | Revenues up 23% compared to last year. Therefore very simplistically, if profits up 23% (could well be conservative) then EPS would be about 73p. Current PE therefore around 13.5. Surely far too cheap for s high quality company, even factoring in some uncertainty about 15% of their future revenues? Particularly as they are making confident noises about replacing it. | hydrus | |
22/8/2016 08:34 | "offset revenues". Pity they aren't more specific, such as "more than offset revenues" or "partly offset revenues". | igbertsponk | |
22/8/2016 08:19 | Very muted reaction for an exceeds expectation announcement, perhaps everyone on holiday still.They are noticeably bolder in their language now about troponin:'we expect to commence significant sales during the financial year ending 30 June 2018, which will offset revenues from other products which are expected to reduce during this period.' | hydrus | |
22/8/2016 08:15 | nor on iii, janeann. Hey ho. I am pleased that my identification of Siemens proved to be correct. Far and away the best partner for eventual entry into the US. The next link in the chain is, in my opinion, being able to justify an interval between tests of an hour. If that happens the whole market will keel over. In the meantime we await loss of revenue in 2017. apad | apad |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions